Cytokinetics Inc vs Shopify Inc. — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Shopify Inc. trades at $151.34 (market cap $196.35B). The key difference: Shopify Inc. is far larger — about 18.5× Cytokinetics Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals.
| CYTK | SHOP | |
|---|---|---|
Market Cap | $10.63B | $196.35B |
Sector | Technology | Technology |
52-Week High | $87.26 | $179.01 |
52-Week Low | $34.31 | $95.40 |
Enterprise Value | $10.74B | $191.59B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Shopify (SHOP) trades at $155.18, up 2.38% today, following strong Q2 2026 earnings beats. The stock exhibits a bullish technical trend with support at $151 and resistance at $158. Revenue growth remains robust, with 2025 revenue reaching $11.56B, though valuation multiples like a P/E of 103.11 are elevated. Positive analyst sentiment is driven by AI commerce integration and expanding gross merchandise volume.
Outlook is positive given earnings momentum and AI-driven growth, but high valuation and competitive e-commerce pressures pose risks. The consensus price target of $166.39 suggests modest upside, supported by 65.62% of analysts rating it Buy. Investors should weigh growth prospects against premium pricing.
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →